Literature DB >> 23277414

Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited.

Kakulavarapu V Rama Rao1, Michael D Norenberg.   

Abstract

Hepatic encephalopathy (HE) is major neuropsychiatric disorder occurring in patients with severe liver disease and ammonia is generally considered to represent the major toxin responsible for this condition. Ammonia in brain is chiefly metabolized ("detoxified") to glutamine in astrocytes due to predominant localization of glutamine synthetase in these cells. While glutamine has long been considered innocuous, a deleterious role more recently has been attributed to this amino acid. This article reviews the mechanisms by which glutamine contributes to the pathogenesis of HE, how glutamine is transported into mitochondria and subsequently hydrolyzed leading to high levels of ammonia, the latter triggering oxidative and nitrative stress, the mitochondrial permeability transition and mitochondrial injury, a sequence of events we have collectively termed as the Trojan horse hypothesis of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23277414      PMCID: PMC4737090          DOI: 10.1007/s11064-012-0955-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  54 in total

Review 1.  Fulminant hepatic failure. Clinical features, etiology, epidemiology, and current management.

Authors:  L Capocaccia; M Angelico
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy.

Authors:  A H Lockwood; E W Yap; H M Rhoades; W H Wong
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

3.  Histochemistry of glutamate metabolizing enzymes in the rat cerebellar cortex.

Authors:  S Würdig; P Kugler
Journal:  Neurosci Lett       Date:  1991-09-16       Impact factor: 3.046

4.  Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats.

Authors:  H Takahashi; R C Koehler; S W Brusilow; R J Traystman
Journal:  Am J Physiol       Date:  1991-09

Review 5.  Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal.

Authors:  Jan Albrecht; Magdalena Zielińska; Michael D Norenberg
Journal:  Biochem Pharmacol       Date:  2010-07-21       Impact factor: 5.858

Review 6.  Acute liver failure.

Authors:  W M Lee
Journal:  Am J Med       Date:  1994-01-17       Impact factor: 4.965

7.  Restoration of cerebrovascular CO2 responsivity by glutamine synthesis inhibition in hyperammonemic rats.

Authors:  H Takahashi; R C Koehler; T Hirata; S W Brusilow; R J Traystman
Journal:  Circ Res       Date:  1992-11       Impact factor: 17.367

8.  Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis.

Authors:  R A Hawkins; J Jessy
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

9.  Brain edema in acute liver failure: inhibition by L-histidine.

Authors:  Kakulavarapu V Rama Rao; Pichili V B Reddy; Xiaoying Tong; Michael D Norenberg
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

10.  Glutaminase in neurons and astrocytes cultured from mouse brain: kinetic properties and effects of phosphate, glutamate, and ammonia.

Authors:  S Hogstad; G Svenneby; I A Torgner; E Kvamme; L Hertz; A Schousboe
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

View more
  23 in total

1.  MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.

Authors:  Brittany A Riggle; Sanhita Sinharay; William Schreiber-Stainthorp; Jeeva P Munasinghe; Dragan Maric; Eva Prchalova; Barbara S Slusher; Jonathan D Powell; Louis H Miller; Susan K Pierce; Dima A Hammoud
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.

Authors:  R Todd Stravitz; Michelle Gottfried; Valerie Durkalski; Robert J Fontana; A James Hanje; David Koch; Bilal Hameed; Daniel Ganger; Ram M Subramanian; Stan Bukofzer; William R Ravis; Kristen Clasen; Averell Sherker; Lanna Little; William M Lee
Journal:  Hepatology       Date:  2018-01-30       Impact factor: 17.425

3.  Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication.

Authors:  G F Cittolin-Santos; A M de Assis; P A Guazzelli; L G Paniz; J S da Silva; M E Calcagnotto; G Hansel; K C Zenki; E Kalinine; M M Duarte; D O Souza
Journal:  Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.590

4.  Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders.

Authors:  Alexei Verkhratsky; Vladimir Parpura
Journal:  Neurobiol Dis       Date:  2015-04-03       Impact factor: 5.996

Review 5.  Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease.

Authors:  Rafael Ochoa-Sanchez; Christopher F Rose
Journal:  J Clin Exp Hepatol       Date:  2018-08-18

Review 6.  Hepatic encephalopathy.

Authors:  Dieter Häussinger; Radha K Dhiman; Vicente Felipo; Boris Görg; Rajiv Jalan; Gerald Kircheis; Manuela Merli; Sara Montagnese; Manuel Romero-Gomez; Alfons Schnitzler; Simon D Taylor-Robinson; Hendrik Vilstrup
Journal:  Nat Rev Dis Primers       Date:  2022-06-23       Impact factor: 65.038

7.  Brain alanine formation as an ammonia-scavenging pathway during hyperammonemia: effects of glutamine synthetase inhibition in rats and astrocyte-neuron co-cultures.

Authors:  Sherry Dadsetan; Eva Kukolj; Lasse K Bak; Michael Sørensen; Peter Ott; Hendrik Vilstrup; Arne Schousboe; Susanne Keiding; Helle S Waagepetersen
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-15       Impact factor: 6.200

8.  Curcumin prevents cognitive deficits in the bile duct ligated rats.

Authors:  Somayeh Baghbaderani; Mehrdad Hashemi; Mohaddaseh Ebrahimi-Ghiri; Mohammad-Reza Zarrindast; Mohammad Nasehi; Maliheh Entezari
Journal:  Psychopharmacology (Berl)       Date:  2020-08-06       Impact factor: 4.530

9.  Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy.

Authors:  Massimo Marano; Umberto Vespasiani Gentilucci; Claudia Altamura; Mariacristina Siotto; Rosanna Squitti; Serena Bucossi; Livia Quintiliani; Simone Migliore; Federico Greco; Laura Scarciolla; Carlo Cosimo Quattrocchi; Antonio Picardi; Fabrizio Vernieri
Journal:  Metab Brain Dis       Date:  2015-08-27       Impact factor: 3.584

Review 10.  Neuroimaging in alcohol use disorder: From mouse to man.

Authors:  Michael Fritz; Anna M Klawonn; Natalie M Zahr
Journal:  J Neurosci Res       Date:  2019-04-22       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.